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Abstract
Background To compare the success rate of monocanalic-
ular intubation (MCI) compared with bicanalicular silicone
intubation (BCI) in congenital nasolacrimal duct obstruc-
tion (CNLDO) in infants and toddlers.
Methods In a prospective, nonrandomized, comparative
study, MCI (n=35 eyes) through the inferior canaliculus or
BCI (n=35 eyes) were performed under general anaesthesia
in children aged 10 to 36 months with CNLDO. The tubes
were removed 3–4 months after tube placement, and the
children were followed up for 6 months after the removal of
tubes. Therapeutic success was defined as the fluorescein
dye disappearance test grade 0–1, corresponding with a
complete resolution of previous symptoms. Partial success
was defined as improvement with some residual symptoms.
Results Complete and partial improvement was achieved in
31/35 (88.57%) in the BCI group and 34/35 (97.14%) in the
MCI group. The difference between the two groups was not
significant (p=0.584). Complications occurred in both
groups. Dislodgement of the tube and premature removal
was observed in four BCI cases, and loss of the tube was
observed twice in the MCI group. Canalicular slitting was
observed in five eyes in the BCI group. Granuloma
pyogenicum observed in 2 cases with MCI revealed a few
weeks after the tube removal. Corneal erosion in the inferior
medial quadrant was observed in one MCI eye and revealed
in a few days after the local treatment without tube removal.
Conclusions Both MCI and the BCI are effective methods
for treating CNLDO. MCI has the advantage of a lower
incidence of canalicular slit and easy placement.
Keywords Congenital nasolacrimal duct obstruction.
Monocanalicular intubation.Bicanalicular intubation.
Complications.Lacrimal
Introduction
Silicone intubation of the lacrimal system has become very
popular in the treatment of congenital nasolacrimal duct
obstructions (CNLDO) resistant to conservative therapy
and/or probing [1–6]. Bicanalicular intubation (BCI) has
been used since the 1970s, and various techniques have
been described, whereas monocanalicular intubation (MCI)
was not popular until the early 1990s [1, 6–8].
Each of these intubation systems has advantages and
disadvantages [2, 3, 5–7, 9]. Whereas the bicanalicular
system requires passing a tube through the inferior and
superior puncta and through the lacrimal system into the
nose, the monocanalicular system requires a single pass of
the tube through the system [1, 2, 4]. Nevertheless, a
comparison of the two kinds of intubation to determine
which is optimal has not been well-performed so far. The
objective of this study was to compare the success rate and
complications of MCI and BCI in children treated for
CNLDO.
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Study design
The aim of this prospective study was to compare the
success rate of MCI and BCI silicone intubations in the
treatment of children with CNLDO. The study was
performed in accordance with the Declaration of Helsinki,
Good Clinical Practice, and applicable regulatory require-
ments. Informed written consent was obtained from all
parents/guardians before the initiation of any procedure.
Children aged between 12 and 36 months with severe
CNLDO symptoms resistant to conservative therapy and two
probings were included in the study. The diagnosis of
CNLDO was based on a history of tearing, the fluorescein
dye disappearance test (FDT), and diagnostic probing and/or
irrigation tests. The study was carried out from January 2006
toNovember2009,andatotalof70eyes(in53children)were
included.
Children younger than 10 months of age were excluded
because of known self-resolution during maturation of the
nasolacrimal duct. Patients with previous eyelid and/or
lacrimal surgery, punctal and/or canalicular obstructions,
eyelid malpositioning, and less than 6 months follow-up
were also excluded.
Time points and follow up clinical examinations
The study started with 35 consecutive cases of BCI (group
I) followed by 35 consecutive cases of MCI (group II). The
silicone tubes were removed 3 to 4 months after the
surgery, and the children were followed up for 6 months.
The drainage function of the lacrimal system was
assessed using a combination of the FDT, medical history
and clinical examinations (tear retention and conjunctival
sac evaluation, medial canthus observation and/or palpa-
tion), as well as syringing of the system in some cases, as
required. However, the history and the FDT were consid-
ered to be the major endpoints.
Complete therapeutic success was defined as FDT grade
0–1, and this result had to correspond with a complete
resolution of previous symptoms. Partial success was
defined as FDT 0–1 with substantial improvement and
some residual symptoms. Failure was defined as the
absence of improvement or the worsening of the symptoms.
For the statistical analysis χ
2-test, Fisher's exact test,
and the two-sample t-test were used, with the level of
significance set at p<0.05.
Procedure technique
After probing the lacrimal pathways with the help of a
Bowman probe, endoscopy of the inferior meatus with the
help of a rigid Hopkins endoscope, 30° and 2.7 mm in
diameter, was performed after infraction of the inferior
concha. If the probe was placed submucously, a focused
incision of the mucous membrane was made, and the end of
the probe was released in the inferior nasal meatus.
For intubations, bicanalicular and monocanalicular sili-
cone sets were used (ELLA-CS, M. Horákové 504, 500 06
Hradec Králové, Czech Republic, phone +420 495 279 111,
www.ellacs.cz).
After probing the lacrimal system through the inferior
canaliculus with a metal probe in the bicanalicular set, a
titanium sling was then put on the tip of the probe into the
inferior meatus under endoscopic control, and the metal
probe was pulled out of the nose by pulling the handle of
the sling and pressing down on the ocular end of the probe
[10]. After introducing the other probe of an intubation set
into the lacrimal pathways through the upper lacrimal
punctum, the probe was also pulled out of the inferior nasal
meatus in the same way. The whole procedure was
completed by knotting both tubes and placing the knot into
the inferior nasal meatus.
For the monocanalicular intubation setting, the silicone
tube (with the ocular anchor and flange) atraumatically
connected with the metal rod was inserted through the
lower canaliculus in a similar way (Fig. 1). The nasal end of
the metal rod was then pulled into the nose and the ocular
end of the tubing was fixed in the punctual ampulla and
secured with a punctual anchor, while the tube was gently
tracted on the distal (nasal) end. After punctual footplate
placement, the distal end of the tubing was cut and left to
dangle freely in the inferior nasal meatus.
When removing the BCI while the patient was under
local anaesthesia, the silicone tube was removed after the
knot had been drawn up through the lacrimal pathways into
the conjuctival sac. The MCI was removed by pulling it out
with forceps at the lacrimal punctum while the patient was
under local anaesthesia.
Results
Seventy eyes of 53 patients were studied. Bicanalicular
intubation was performed in 35 eyes (24 children; group I)
and monocanalicular in 35 (29 children; group II). The
youngest patient was 10 months of age and the oldest was
32 months of age (Fig. 2). Thirty-nine eyes were from
female patients, and 31 from male patients. The right eye
was involved in 39 cases. Tubes were usually removed
between 3 and 4 months after the surgery in an office
setting (Figs. 3, 4).
In group I, complete resolution of symptoms was
observed in 29/35 cases (82.86%), partial resolution in 2/
35 (5.71%), and failure in four cases (11.43%) (Table 1). In
1730 Graefes Arch Clin Exp Ophthalmol (2011) 249:1729–1733group II, the complete resolution of symptoms was observed
in 31/35 eyes (88.57%), partial success in 3/35 eyes (8.57%),
and failure in 1/35 eyes (2.86%). Therefore, complete and
partial success was achieved in31/35 (88.57%) ingroup I and
in 34/35 (97.14%) in group II. The success rate (complete +
partial success) in group II (MCI) was not significantly higher
thanthatofgroupI(BCI)(p=0.584). There was found no age
nor sex predominance.
Complications
Dislodging of the tube and premature removal was
observed in four cases in group I (1, 2, 4, and 8 weeks
after intubation respectively), whereas loss of the tube was
observed twice (1 week after intubation in one case, and in
one case the parents did not specify the time of the loss) in
group II (Table 2). In children with premature tube removal,
improvement of symptoms was observed in 3/4 eyes in
group I (75.0%), and in 2/2 eyes in group II (100.0%).
Slitting of the punctum and canaliculi were observed in
five eyes with BCI (group I) and none with MCI (group II).
Granuloma pyogenicum was found in two cases with MCI
and completely revealed during 2 months after tube
removal without any specific treatment.
Corneal erosion in the inferior medial quadrant was
observed in one eye treated with MCI shortly after tube
placement, and resolved within a few days after local
treatment; it was not necessary to remove the tube
prematurely.
Discussion
Silicone intubation was first described by Quickert and
Dryden in 1970 and the procedure has become part of the
standard management of CNLDO [2, 3, 6]. Among the
factors that affect the treatment success of CNLDO are age,
severity of symptoms, the history of previous interventions,
time of the interventions, and compliance with treatment.
However, there are no generally accepted and defined rules
concerning age, length of intubation, and/or different
variations in intubation systems [6, 11].
Although tube placement in children requires general
anesthesia, the normal anatomy of the lacrimal system is
not destroyed, and the success rates range from 80% to
100% [1–3, 6, 12]. BCI has been used more frequently, not
only for treatment of CNLDO, but also for dacryocysto-
rhinostomy, canalicular stenose, etc. [2, 6].
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Fig. 3 Bicanalicular intubation in CNLDO; success rate according to
age
Fig. 2 Monocanalicular intubation showing the position of the flange
on the eyelid margin after tube fixation
Fig. 1 Monocanalicular intuba-
tion set (ELLA-CS, Czech
Republic) — in detail
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use BCI or MCI is the number of complications [1–3, 6].
One of the main advantages of BCI is that BCI is generally
very well-tolerated by the cornea because it is significantly
smoother than MCI [1, 7, 9]. If MCI is used, corneal
abrasions or ulcers can be caused by the ocular end of the
MCI. The abrasions usually occur in the inferior nasal
quadrant (if the tube is fixed in the the inferior canaliculus),
and usually heal in a few days after local treatment [9].
Fayet et al. observed only three (1.5%) corneal ulcers in
223 eyes with MCI, whereas no corneal ulcers were
observed in 1,620 BCI placements [9]. They assumed that
the placement of the MCI in the superior canaliculus is a
predisposing factor for corneal irritation, especially if the
size and length of the collarete is larger [9]. On the other
hand, Engel et al. recommend performing MCI through the
superior canaliculus, and found only a 2% risk of
conjunctival or corneal abrasions in their series of 635
eyes [3]. In our study, in which monocanalicular tubes were
inserted into the inferior canaliculus, corneal abrasion was
observed in only one child (2.8%) a few days after the
surgery. The abrasion healed within 3 days without the
premature removal of the tube. Our experience confirms
that it is necessary to use tubes of an appropriate size with a
small flange (collar) that does not exceed the eyelid margin
and does not irritate the cornea, so that corneal abrasion and
ulceration is prevented. Conversely, Fayet et al. found the
diameter of the collar to be unimportant and without
influence on the rate of corneal erosions [7].
MCI offers a chance to achieve better success rates than
simple probing, and requires only a single pass through the
nasolacrimal system [3]. The technical insertion of MCI as
well as its removal is easy, and the difficulties associated
with BCI are minimized [1, 4]. Based on our 17 years of
experience with lacrimal surgery, we agree that the
manipulation in only one canaliculus may be advantageous
because the risk of possible iatrogenic traumatisation of the
lacrimal system is lower.
Unexpected side-effects should be taken into consider-
ation, too. While we observed no granuloma pyogenicum in
the BCI group, we observed two granulomas in children
who had MCI. Though these occurences resolved a few
weeks after removal of the tube, they seem to be related to
the ocular end of MCI. Fayet et al. recommended not
leaving a MCI in for longer than 3 months to decrease the
likelihood of complications [9]. While we usually removed
MCIs within 3 to 4 months after placing the tubes, the
question of whether or not the number of complications
would increase with longer MCI placement is unclear. In
our study, there were only two children with a longer (5 and
11 months respectively) tube placement (they did not return
for removal of the tube until these times); however, no
complications were observed in these two cases, and full
success was achieved.
In order to prevent damage to the punctum and fibrous
meatal ring while inserting the MCI, an appropriate
technique should be used [7]. That is why performing an
excessively aggressive dilation of the punctum is not
recommended. Fayet, who developed the Monoka system
(FCI, France), recommends only gentle traction on the
distal end at the time of insertion and gentle dilation of the
punctum [7, 9]. A special dilator for inserting the tube can
help to avoid inadvertent damage to the puntal and
canalicular systems [7]. Although we did not use this
dilator, no difficulties during the time of tubing were
observed.
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Fig. 4 Monocanalicular intubation in CNLDO; success rate according
to age
Table 1 Comparison of the bicanalicular and monocanalicular
intubation results
Outcome Group I:
bicanalicular
intubation (35 cases)
Group II:
monocanalicular
intubation (35 cases)
Complete resolution 29 (82.86%) 31 (88.57%)
Partial resolution 2 (5.71%) 3 (8.57%)
Failure 4 (11.4%) 1 (2.86%)
Total 31/35 (88.57%) 34/35 (97.14%)
Table 2 Comparison of the complications observed with bicanalicular
(BCI) and monocanalicular intubation (MCI)
Complications/number Group I BCI Group II MCI
Displacement and premature
removal
4-
Loss - 2
Granuloma pyogenicum - 2
Corneal abrasion/ulcer - 1
Canalicular slitting 5 -
Inflammation of the lacrimal system - -
1732 Graefes Arch Clin Exp Ophthalmol (2011) 249:1729–1733On the other hand, excessive dilation might increase the
incidence of some complications, especially spontaneous
loss of the tubing [7]. This complication was observed in
35.4% in a study of 48 eyes with CNLDO treated with MCI
reported by Kaufman and Guay-Bhatia, where premature
removal was observed in 21 of 48 eyes (43.7%) [1]. Our
results did not confirm these findings. Dislodgement of BCI
causing premature removal was observed in four eyes,
whereas premature loss of the monocanalicular tube was
observed twice.
Few reports compare the success rates of MCI with BCI.
The success rates of BCIs for the treatment of CNLDO
range from 83% to 100% [2, 6, 11, 12]. Feyet et al.
observed complete resolution of epiphora in 67.7% with
Monoka and 62.4% with BCI in their study of 120 cases
[13]. In their study comparing MCI and BCI in 48 eyes of
adults, Kashkouli et al. achieved nearly the same complete
success rate (MCI 61.5%, BCI 59.0%); moreover, higher
partial success and lower failure rate was achieved than in
the group with BCI [4]. In our study, we found no
significant differences in the sucess rates between the BCI
(88.5%) and MCI (97.1%) groups. On the other hand, in the
study by Kaufman et al. of 48 eyes with MCI, full and
partial success was achieved in only 30 cases (78.0%), and
21 cases of premature tube removal occurred (43.7%) [1].
In the study by Engel et al. of 635 children with probing
and MCI, the success rate was 97%, declining to 90% when
surgery was performed in infants older than 24 months of
age [3]. We agree with Engel et al. that, for those patients
with CNLDO requiring general anesthesia, MCI may
reduce recurrence and reoperations, and is an appropriate
alternative in the treatment of CNLDO [3].
Our results raise the question of whether or not it would
be better to prefer MCI over BCI in the treatment of
CNLDO. Although our study supports a preference for
MCI, further prospective, randomised studies would better
determine the advantages and disadvantages of the two
intubation methods.
Conclusion
MCI is very effective in the treatment of CNLDO, and is an
appropriate alternative procedure with a minimum of
complications. The success rates of MCI and BCI were
not significantly different. The use of monocanalicular
intubation is easier to perform; thus, it is a useful method
for the treatment of CNLDO resistant to conservative
therapy and probing.
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